SEC Form 4 · accession 0001562180-18-003975
Intersect ENT, Inc. · XENT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeryl L Hilleman
Officer — Chief Financial Officer
Period of report
Sep 14, 2018
Accepted (ET)
Sep 18, 2018 · 9:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001271214
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 14, 2018 | M | 12,833 | $11.12 | A | 36,265 | D | |
| Common StockF3,F1 | Sep 14, 2018 | S | 12,833 | $28.9224 | D | 23,432 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $11.12 | Sep 14, 2018 | M | 12,833 | D | — | Jun 10, 2024 | Common Stock | 12,833 | 8,167 | D |
Explanation of responses
- F1Includes 20,500 Restricted Stock Units.
- F2The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 14, 2018.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.80 to $29.05, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- F4The shares subject to the option vest commencing June 4, 2014. 25% of the shares subject to the option vested on June 4, 2015 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years.